| scholarly article | Q13442814 |
| P50 | author | Elisabeth Brambilla | Q70964699 |
| Alim-Louis Benabid | Q2836923 | ||
| P2093 | author name string | Ali Bouamrani | |
| David Ratel | |||
| François Berger | |||
| Jean-Paul Issartel | |||
| Jessica Ternier | |||
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 2103-2106 | |
| P577 | publication date | 2006-09-21 | |
| P1433 | published in | Clinical Chemistry | Q849687 |
| P1476 | title | Direct-tissue SELDI-TOF mass spectrometry analysis: a new application for clinical proteomics | |
| P478 | volume | 52 |
| Q36322804 | Advances in MALDI imaging mass spectrometry of proteins in cardiac tissue, including the heart valve |
| Q36965370 | Applications of emerging molecular technologies in glioblastoma multiforme |
| Q37139413 | Clinical biomarkers of angiogenesis inhibition |
| Q34371208 | Construction of protein profile classification model and screening of proteomic signature of acute leukemia |
| Q34022213 | Enriched sera protein profiling for detection of non-small cell lung cancer biomarkers |
| Q35867858 | Identification of carboxyl terminal peptide of Fibrinogen as a potential serum biomarker for gastric cancer |
| Q33856292 | Identification of proteomic signatures of mantle cell lymphoma, small lymphocytic lymphoma, and marginal zone lymphoma biopsies by surface enhanced laser desorption/ionization-time of flight mass spectrometry |
| Q33310726 | Identification of serum biomarkers for nasopharyngeal carcinoma by proteomic analysis. |
| Q33891208 | Identification of serum protein markers for breast cancer relapse with SELDI-TOF MS. |
| Q28748900 | Increased phosphorylation of vimentin in noninfiltrative meningiomas |
| Q35405129 | Increasing specificity in imaging mass spectrometry: high spatial fidelity transfer of proteins from tissue sections to functionalized surfaces |
| Q35778587 | Introducing specificity and sensitivity in imaging MS. |
| Q30475508 | Mass spectrometric imaging for biomedical tissue analysis |
| Q37484011 | Mass spectrometry based proteomics profiling as diagnostic tool in oncology: current status and future perspective |
| Q36841889 | Oncoproteomics: current trends and future perspectives. |
| Q35627301 | Potential Serum Markers for Monitoring the Progression of Hepatitis B Virus-Associated Chronic Hepatic Lesions to Liver Cirrhosis |
| Q36841875 | Proteomic analysis of bone cancer: a review of current and future developments. |
| Q33427421 | Proteomic profiles differ between bone invasive and noninvasive benign meningiomas of fibrous and meningothelial subtype |
| Q36787244 | Proteomics in atherothrombosis: a future perspective |
| Q35170365 | Proteomics of gliomas: initial biomarker discovery and evolution of technology |
| Q36913050 | Recent advances in protein profiling of tissues and tissue fluids |
| Q33748119 | Reference spectra from squamous epithelium and connective tissue allow whole section proteomics analysis |
| Q33470022 | SELDI-TOF MS profiling of serum for detection of nasopharyngeal carcinoma. |
| Q33370724 | Surface enhanced laser desorption/ionization (SELDI): proteomics technology and its application in oncology |
| Q33266573 | [Research progress in SELDI-TOF MS and its clinical applications]. |
Search more.